Regulatory T cell subsets in human cancer: are they regulating for or against tumor progression?
TL Whiteside - Cancer Immunology, Immunotherapy, 2014 - Springer
Regulatory T cells (Treg) play a key role in maintaining the balance of immune responses in
human health and in disease. Treg come in many flavors and can utilize a variety of …
human health and in disease. Treg come in many flavors and can utilize a variety of …
Evaluating the role of IDO1 macrophages in immunotherapy using scRNA-seq and bulk-seq in colorectal cancer
X Liu, G Yan, B Xu, H Yu, Y An, M Sun - Frontiers in Immunology, 2022 - frontiersin.org
Background Macrophage infiltration is crucial for colorectal cancer (CRC) immunotherapy.
Detailed classification of macrophage subsets will facilitate the selection of patients suitable …
Detailed classification of macrophage subsets will facilitate the selection of patients suitable …
[HTML][HTML] Differential gene expression of tumor-infiltrating CD8+ T cells in advanced versus early-stage colorectal cancer and identification of a gene signature of poor …
Background Cytotoxic CD8+ T cell-mediated response is the most important arm of adaptive
immunity, which dictates the capacity of the host immune response in eradicating tumor …
immunity, which dictates the capacity of the host immune response in eradicating tumor …
Targeting MEK/COX-2 axis improve immunotherapy efficacy in dMMR colorectal cancer with PIK3CA overexpression
K Peng, Y Liu, S Liu, Z Wang, H Zhang, W He, Y Jin… - Cellular Oncology, 2024 - Springer
Purpose PIK3CA mutation or overexpression is associated with immunotherapy resistance
in multiple cancer types, but is also paradoxically associated with benefit of COX-2 inhibition …
in multiple cancer types, but is also paradoxically associated with benefit of COX-2 inhibition …
Intratumoral regulatory T cells: markers, subsets and their impact on anti‐tumor immunity
H Yano, LP Andrews, CJ Workman, DAA Vignali - Immunology, 2019 - Wiley Online Library
Regulatory T (Treg) cells play a crucial role in maintaining self‐tolerance and resolution of
immune responses by employing multifaceted immunoregulatory mechanisms. However …
immune responses by employing multifaceted immunoregulatory mechanisms. However …
Immune checkpoints expression in MSI versus MSS colorectal cancers and their potential therapeutic implications.
NJ Llosa, F Housseau, EC Wick, L Hechenbleikner… - 2014 - ascopubs.org
3620 Background: Colorectal cancer (CRC) is divided into 2 groups based on genomic
differences: chromosomal instability (80%), and microsatellite instability (MSI)(20%). MSI …
differences: chromosomal instability (80%), and microsatellite instability (MSI)(20%). MSI …
Digital analysis and epigenetic regulation of the signature of rejection in colorectal cancer
VH Koelzer, L Sokol, S Zahnd, L Christe… - …, 2017 - Taylor & Francis
The immune system plays a pivotal role in the development and progression of colorectal
cancer (CRC). Tumor immune rejection has been previously linked to the activation of the …
cancer (CRC). Tumor immune rejection has been previously linked to the activation of the …
The miRNA profile of inflammatory colorectal tumors identify TGF-β as a companion target for checkpoint blockade immunotherapy
B Bartlett, Z Gao, M Schukking, M Menor… - Frontiers in Cell and …, 2021 - frontiersin.org
Extrinsic factors such as expression of PD-L1 (programmed dealth-ligand 1) in the tumor
microenvironment (TME) have been shown to correlate with responses to checkpoint …
microenvironment (TME) have been shown to correlate with responses to checkpoint …
Associations of different immune checkpoints-expressing CD4+ Treg/ T cell subsets with disease-free survival in colorectal cancer patients
There are different subsets of T regulatory cells (Tregs), orchestrating critical roles in the
regulation of anti-tumor immunity in colorectal cancer (CRC). In this study, we report that a …
regulation of anti-tumor immunity in colorectal cancer (CRC). In this study, we report that a …
RIG-I resists hypoxia-induced immunosuppression and dedifferentiation
C Engel, G Brügmann, S Lambing… - Cancer Immunology …, 2017 - AACR
A hypoxic tumor microenvironment is linked to poor prognosis. It promotes tumor cell
dedifferentiation and metastasis and desensitizes tumor cells to type-I IFN, chemotherapy …
dedifferentiation and metastasis and desensitizes tumor cells to type-I IFN, chemotherapy …